Syntaxin 6 and CAL mediate the degradation of the cystic fibrosis transmembrane conductance regulator
- PMID: 20130090
- PMCID: PMC2847522
- DOI: 10.1091/mbc.e09-03-0229
Syntaxin 6 and CAL mediate the degradation of the cystic fibrosis transmembrane conductance regulator
Abstract
The PDZ domain-containing protein CAL mediates lysosomal trafficking and degradation of CFTR. Here we demonstrate the involvement of a CAL-binding SNARE protein syntaxin 6 (STX6) in this process. Overexpression of STX6, which colocalizes and coimmunoprecipitates with CAL, dramatically reduces the steady-state level and stability of CFTR. Conversely, overexpression of a STX6 dominant-negative mutant increases CFTR. Silencing endogenous STX6 increases CFTR but has no effect on DeltaTRL-CFTR, which cannot bind to CAL. Silencing CAL eliminates the effect of STX6 on CFTR. Both results suggest a dependence of CAL on STX6 function. Consistent with its Golgi localization, STX6 does not bind to ER-localized DeltaF508-CFTR. Silencing STX6 has no effect on DeltaF508-CFTR expression. However, overexpression of STX6 coimmunoprecipitates with and reduces temperature-rescued DeltaF508-CFTR that escapes ER degradation. Conversely, silencing STX6 enhances the effect of low temperature in rescuing DeltaF508-CFTR. Finally, in human bronchial epithelial cells, silencing endogenous STX6 leads to increases in protein levels and Cl(-) currents of both wild-type and temperature-rescued CFTR. We have identified STX6 as a new component of the CAL complex that regulates the abundance and function of CFTR at the post-ER level. Our results suggest a therapeutic role of STX6 in enhancing rescued DeltaF508-CFTR.
Figures








Similar articles
-
Ubiquitination and degradation of CFTR by the E3 ubiquitin ligase MARCH2 through its association with adaptor proteins CAL and STX6.PLoS One. 2013 Jun 20;8(6):e68001. doi: 10.1371/journal.pone.0068001. Print 2013. PLoS One. 2013. PMID: 23818989 Free PMC article.
-
Targeting CAL as a negative regulator of DeltaF508-CFTR cell-surface expression: an RNA interference and structure-based mutagenetic approach.J Biol Chem. 2007 Mar 16;282(11):8099-109. doi: 10.1074/jbc.M611049200. Epub 2006 Dec 11. J Biol Chem. 2007. PMID: 17158866
-
A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression.J Biol Chem. 2002 Feb 1;277(5):3520-9. doi: 10.1074/jbc.M110177200. Epub 2001 Nov 13. J Biol Chem. 2002. PMID: 11707463
-
The cystic fibrosis transmembrane conductance regulator's expanding SNARE interactome.Traffic. 2011 Apr;12(4):364-71. doi: 10.1111/j.1600-0854.2011.01161.x. Epub 2011 Feb 8. Traffic. 2011. PMID: 21223469 Review.
-
Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi.FEBS J. 2013 Sep;280(18):4396-406. doi: 10.1111/febs.12392. Epub 2013 Jul 5. FEBS J. 2013. PMID: 23773658 Review.
Cited by
-
GOPC facilitates the sorting of syndecan-1 in polarized epithelial cells.Mol Biol Cell. 2022 Sep 1;33(10):ar86. doi: 10.1091/mbc.E22-05-0165. Epub 2022 Jul 13. Mol Biol Cell. 2022. PMID: 35830596 Free PMC article.
-
Microtubule-Associated Serine/Threonine (MAST) Kinases in Development and Disease.Int J Mol Sci. 2023 Jul 25;24(15):11913. doi: 10.3390/ijms241511913. Int J Mol Sci. 2023. PMID: 37569286 Free PMC article. Review.
-
Regulation of CFTR Biogenesis by the Proteostatic Network and Pharmacological Modulators.Int J Mol Sci. 2020 Jan 10;21(2):452. doi: 10.3390/ijms21020452. Int J Mol Sci. 2020. PMID: 31936842 Free PMC article. Review.
-
Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease.Genes (Basel). 2020 May 13;11(5):546. doi: 10.3390/genes11050546. Genes (Basel). 2020. PMID: 32414011 Free PMC article. Review.
-
Targets for cystic fibrosis therapy: proteomic analysis and correction of mutant cystic fibrosis transmembrane conductance regulator.Expert Rev Proteomics. 2010 Aug;7(4):495-506. doi: 10.1586/epr.10.45. Expert Rev Proteomics. 2010. PMID: 20653506 Free PMC article. Review.
References
-
- Benharouga M., Sharma M., So J., Haardt M., Drzymala L., Popov M., Schwapach B., Grinstein S., Du K., Lukacs G. L. The role of the C terminus and Na+/H+ exchanger regulatory factor in the functional expression of cystic fibrosis transmembrane conductance regulator in nonpolarized cells and epithelia. J. Biol. Chem. 2003;278:22079–22089. - PubMed
-
- Bilan F., Thoreau V., Nacfer M., Derand R., Norez C., Cantereau A., Garcia M., Becq F., Kitzis A. Syntaxin 8 impairs trafficking of cystic fibrosis transmembrane conductance regulator (CFTR) and inhibits its channel activity. J. Cell Sci. 2004;117:1923–1935. - PubMed
-
- Boucher R. C. Airway surface dehydration in cystic fibrosis: pathogenesis and therapy. Annu. Rev. Med. 2007;58:157–170. - PubMed
-
- Cai H., Reinisch K., Ferro-Novick S. Coats, tethers, Rabs, and SNAREs work together to mediate the intracellular destination of a transport vesicle. Dev. Cell. 2007;12:671–682. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous